Abstract
Bordetella pertussis produces several toxins that affect host-pathogen interactions. Of these, the major toxins that contribute to pertussis infection and disease are pertussis toxin, adenylate cyclase toxin-hemolysin and tracheal cytotoxin. Pertussis toxin is a multi-subunit protein toxin that inhibits host G protein-coupled receptor signaling, causing a wide array of effects on the host. Adenylate cyclase toxin-hemolysin is a single polypeptide, containing an adenylate cyclase enzymatic domain coupled to a hemolysin domain, that primarily targets phagocytic cells to inhibit their antibacterial activities. Tracheal cytotoxin is a fragment of peptidoglycan released by B. pertussis that elicits damaging inflammatory responses in host cells. This chapter describes these three virulence factors of B. pertussis, summarizing background information and focusing on the role of each toxin in infection and disease pathogenesis, as well as their role in pertussis vaccination.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adamson PB, Hull SS Jr, Vanoli E, De Ferrari GM, Wisler P, Foreman RD, Watanabe AM, Schwartz PJ (1993) Pertussis toxin-induced ADP ribosylation of inhibitor G proteins alters vagal control of heart rate in vivo. Am J Phys 265(2 Pt 2):H734–H740
Agarwal N, Lamichhane G, Gupta R, Nolan S, Bishai WR (2009) Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase. Nature 460(7251):98–102
Ahmad JN, Cerny O, Linhartova I, Masin J, Osicka R, Sebo P (2016) cAMP signalling of Bordetella adenylate cyclase toxin through the SHP-1 phosphatase activates the BimEL-Bax pro-apoptotic cascade in phagocytes. Cell Microbiol 18(3):384–398
Andreasen C, Carbonetti NH (2008) Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice. Infect Immun 76(11):5139–5148
Andreasen C, Carbonetti NH (2009) Role of neutrophils in response to Bordetella pertussis infection in mice. Infect Immun 77(3):1182–1188
Andreasen C, Powell DA, Carbonetti NH (2009) Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice. PLoS One 4(9):e7079
Arimoto H, Tanuma N, Jee Y, Miyazawa T, Shima K, Matsumoto Y (2000) Analysis of experimental autoimmune encephalomyelitis induced in F344 rats by pertussis toxin administration. J Neuroimmunol 104(1):15–21
Arp LH, Fagerland JA (1987) Ultrastructural pathology of Bordetella avium infection in turkeys. Vet Pathol 24(5):411–418
Bargatze RF, Butcher EC (1993) Rapid G protein-regulated activation event involved in lymphocyte binding to high endothelial venules. J Exp Med 178(1):367–372
Basler M, Masin J, Osicka R, Sebo P (2006) Pore-forming and enzymatic activities of Bordetella pertussis adenylate cyclase toxin synergize in promoting lysis of monocytes. Infect Immun 74(4):2207–2214
Bassinet L, Gueirard P, Maitre B, Housset B, Gounon P, Guiso N (2000) Role of adhesins and toxins in invasion of human tracheal epithelial cells by Bordetella pertussis. Infect Immun 68(4):1934–1941
Beck TC, Gomes AC, Cyster JG, Pereira JP (2014) CXCR4 and a cell-extrinsic mechanism control immature B lymphocyte egress from bone marrow. J Exp Med 211(13):2567–2581
Bemis DA (1992) Bordetella and Mycoplasma respiratory infections in dogs and cats. Vet Clin North Am Small Anim Pract 22(5):1173–1186
Bennett J, Basivireddy J, Kollar A, Biron KE, Reickmann P, Jefferies WA, McQuaid S (2010) Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE. J Neuroimmunol 229(1–2):180–191
Benz R, Maier E, Ladant D, Ullmann A, Sebo P (1994) Adenylate cyclase toxin (CyaA) of Bordetella pertussis. Evidence for the formation of small ion-permeable channels and comparison with HlyA of Escherichia coli. J Biol Chem 269(44):27231–27239
Boehm DT, Hall JM, Wong TY, DiVenere AM, Sen-Kilic E, Bevere JR, Bradford SD, Blackwood CB, Elkins CM, DeRoos KA, Gray MC, Cooper CG, Varney ME, Maynard JA, Hewlett EL, Barbier M, Damron FH (2018) Evaluation of adenylate cyclase toxoid antigen in acellular pertussis vaccines by using a Bordetella pertussis challenge model in mice. Infect Immun 86(10)
Boothby D, Daneo-Moore L, Higgins ML, Coyette J, Shockman GD (1973) Turnover of bacterial cell wall peptidoglycans. J Biol Chem 248(6):2161–2169
Bouchez V, Brun D, Cantinelli T, Dore G, Njamkepo E, Guiso N (2009) First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin. Vaccine 27(43):6034–6041
Boyd AP, Ross PJ, Conroy H, Mahon N, Lavelle EC, Mills KH (2005) Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death. J Immunol 175(2):730–738
Bruss JB, Malley R, Halperin S, Dobson S, Dhalla M, McIver J, Siber GR (1999) Treatment of severe pertussis: a study of the safety and pharmacology of intravenous pertussis immunoglobulin. Pediatr Infect Dis J 18(6):505–511
Bumba L, Masin J, Fiser R, Sebo P (2010) Bordetella adenylate cyclase toxin mobilizes its beta2 integrin receptor into lipid rafts to accomplish translocation across target cell membrane in two steps. PLoS Pathog 6(5):e1000901
Bumba L, Masin J, Macek P, Wald T, Motlova L, Bibova I, Klimova N, Bednarova L, Veverka V, Kachala M, Svergun DI, Barinka C, Sebo P (2016) Calcium-driven folding of RTX domain beta-rolls ratchets translocation of RTX proteins through type I secretion ducts. Mol Cell 62(1):47–62
Carbonetti NH (2010) Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools. Future Microbiol 5(3):455–469
Carbonetti NH (2016) Pertussis leukocytosis: mechanisms, clinical relevance and treatment. Pathog Dis 74:ftw087. https://doi.org/10.1093/femspd/ftw087
Carbonetti NH, Artamonova GV, Mays RM, Worthington ZE (2003) Pertussis toxin plays an early role in respiratory tract colonization by Bordetella pertussis. Infect Immun 71(11):6358–6366
Carbonetti NH, Artamonova GV, Andreasen C, Dudley E, Mays RM, Worthington ZE (2004) Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein. Infect Immun 72(6):3350–3358
Carbonetti NH, Artamonova GV, Andreasen C, Bushar N (2005) Pertussis toxin and adenylate cyclase toxin provide a one-two punch for establishment of Bordetella pertussis infection of the respiratory tract. Infect Immun 73(5):2698–2703
Carbonetti NH, Artamonova GV, Van Rooijen N, Ayala VI (2007) Pertussis toxin targets airway macrophages to promote Bordetella pertussis infection of the respiratory tract. Infect Immun 75(4):1713–1720
Cerny O, Kamanova J, Masin J, Bibova I, Skopova K, Sebo P (2015) Bordetella pertussis adenylate cyclase toxin blocks induction of bactericidal nitric oxide in macrophages through cAMP-dependent activation of the SHP-1 Phosphatase. J Immunol 194(10):4901–4913
Chaloupka J, Strnadova M (1972) Turnover of murein in a diaminopimelic acid dependent mutant of Escherichia coli. Folia Microbiol (Praha) 17(6):446–455
Chattopadhyay R, Mani AM, Singh NK, Rao GN (2018) Resolvin D1 blocks H2O2-mediated inhibitory crosstalk between SHP2 and PP2A and suppresses endothelial-monocyte interactions. Free Radic Biol Med 117:119–131
Chen Z, He Q (2017) Immune persistence after pertussis vaccination. Hum Vaccin Immunother 13(4):744–756. https://doi.org/10.1080/21645515.2016.1259780
Cheung GY, Xing D, Prior S, Corbel MJ, Parton R, Coote JG (2006) Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model. Infect Immun 74(12):6797–6805
Confer DL, Eaton JW (1982) Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science 217(4563):948–950
Connelly CE, Sun Y, Carbonetti NH (2012) Pertussis toxin exacerbates and prolongs airway inflammatory responses during Bordetella pertussis infection. Infect Immun 80(12):4317–4332
Cookson BT, Cho HL, Herwaldt LA, Goldman WE (1989a) Biological activities and chemical composition of purified tracheal cytotoxin of Bordetella pertussis. Infect Immun 57(7):2223–2229
Cookson BT, Tyler AN, Goldman WE (1989b) Primary structure of the peptidoglycan-derived tracheal cytotoxin of Bordetella pertussis. Biochemistry 28(4):1744–1749
Coutte L, Locht C (2015) Investigating pertussis toxin and its impact on vaccination. Future Microbiol 10:241–254
Cundell DR, Kanthakumar K, Taylor GW, Goldman WE, Flak T, Cole PJ, Wilson R (1994) Effect of tracheal cytotoxin from Bordetella pertussis on human neutrophil function in vitro. Infect Immun 62(2):639–643
Dalby T, Andersen PH, Hoffmann S (2016) Epidemiology of pertussis in Denmark, 1995 to 2013. Euro Surveill 21(36)
Doino JA, McFall-Ngai MJ (1995) A transient exposure to symbiosis-competent bacteria induces light organ morphogenesis in the host squid. Biol Bull 189(3):347–355
Dudek SM, Camp SM, Chiang ET, Singleton PA, Usatyuk PV, Zhao Y, Natarajan V, Garcia JG (2007) Pulmonary endothelial cell barrier enhancement by FTY720 does not require the S1P1 receptor. Cell Signal 19(8):1754–1764
Dunne A, Ross PJ, Pospisilova E, Masin J, Meaney A, Sutton CE, Iwakura Y, Tschopp J, Sebo P, Mills KH (2010) Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis. J Immunol 185(3):1711–1719
Eby JC, Ciesla WP, Hamman W, Donato GM, Pickles RJ, Hewlett EL, Lencer WI (2010) Selective translocation of the Bordetella pertussis adenylate cyclase toxin across the basolateral membranes of polarized epithelial cells. J Biol Chem 285(14):10662–10670
Eby JC, Gray MC, Hewlett EL (2014) Cyclic AMP-mediated suppression of neutrophil extracellular trap formation and apoptosis by the Bordetella pertussis adenylate cyclase toxin. Infect Immun 82(12):5256–5269
el Baya A, Linnemann R, von Olleschik-Elbheim L, Robenek H, Schmidt MA (1997) Endocytosis and retrograde transport of pertussis toxin to the Golgi complex as a prerequisite for cellular intoxication. Eur J Cell Biol 73(1):40–48
Endoh M, Takezawa T, Nakase Y (1980) Adenylate cyclase activity of Bordetella organisms. I. Its production in liquid medium. Microbiol Immunol 24(2):95–104
Endoh M, Amitani M, Nakase Y (1986) Purification and characterization of heat-labile toxin from Bordetella bronchiseptica. Microbiol Immunol 30(7):659–673
Ernst K, Eberhardt N, Mittler AK, Sonnabend M, Anastasia A, Freisinger S, Schiene-Fischer C, Malesevic M, Barth H (2018) Pharmacological cyclophilin inhibitors prevent intoxication of mammalian cells with Bordetella pertussis toxin. Toxins 10(5)
Fedele G, Spensieri F, Palazzo R, Nasso M, Cheung GY, Coote JG, Ausiello CM (2010) Bordetella pertussis commits human dendritic cells to promote a Th1/Th17 response through the activity of adenylate cyclase toxin and MAPK-pathways. PLoS One 5(1):e8734
Fedele G, Bianco M, Debrie AS, Locht C, Ausiello CM (2011) Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1/Th17 response. J Immunol 186(9):5388–5396
Feunou PF, Kammoun H, Debrie AS, Mielcarek N, Locht C (2010) Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1. Vaccine 28(43):7047–7053
Finck-Barbancon V, Barbieri JT (1996) Preferential processing of the S1 subunit of pertussis toxin that is bound to eukaryotic cells. Mol Microbiol 22(1):87–95
Fiser R, Masin J, Basler M, Krusek J, Spulakova V, Konopasek I, Sebo P (2007) Third activity of Bordetella adenylate cyclase (AC) toxin-hemolysin. Membrane translocation of AC domain polypeptide promotes calcium influx into CD11b+ monocytes independently of the catalytic and hemolytic activities. J Biol Chem 282(5):2808–2820
Fiser R, Masin J, Bumba L, Pospisilova E, Fayolle C, Basler M, Sadilkova L, Adkins I, Kamanova J, Cerny J, Konopasek I, Osicka R, Leclerc C, Sebo P (2012) Calcium influx rescues adenylate cyclase-hemolysin from rapid cell membrane removal and enables phagocyte permeabilization by toxin pores. PLoS Pathog 8(4):e1002580
Flak TA, Goldman WE (1999) Signalling and cellular specificity of airway nitric oxide production in pertussis. Cell Microbiol 1(1):51–60
Flak TA, Heiss LN, Engle JT, Goldman WE (2000) Synergistic epithelial responses to endotoxin and a naturally occurring muramyl peptide. Infect Immun 68(3):1235–1242
Folkening WJ, Nogami W, Martin SA, Rosenthal RS (1987) Structure of Bordetella pertussis peptidoglycan. J Bacteriol 169(9):4223–4227
Friedman RL, Fiederlein RL, Glasser L, Galgiani JN (1987) Bordetella pertussis adenylate cyclase: effects of affinity-purified adenylate cyclase on human polymorphonuclear leukocyte functions. Infect Immun 55(1):135–140
Gentry-Weeks CR, Cookson BT, Goldman WE, Rimler RB, Porter SB, Curtiss R 3rd (1988) Dermonecrotic toxin and tracheal cytotoxin, putative virulence factors of Bordetella avium. Infect Immun 56(7):1698–1707
Glaser P, Ladant D, Sezer O, Pichot F, Ullmann A, Danchin A (1988a) The calmodulin-sensitive adenylate cyclase of Bordetella pertussis: cloning and expression in Escherichia coli. Mol Microbiol 2(1):19–30
Glaser P, Sakamoto H, Bellalou J, Ullmann A, Danchin A (1988b) Secretion of cyclolysin, the calmodulin-sensitive adenylate cyclase-haemolysin bifunctional protein of Bordetella pertussis. EMBO J 7(12):3997–4004
Goldman WE, Cookson BT (1988) Structure and functions of the Bordetella tracheal cytotoxin. Tokai J Exp Clin Med 13(Suppl):187–191
Goldman WE, Klapper DG, Baseman JB (1982) Detection, isolation, and analysis of a released Bordetella pertussis product toxic to cultured tracheal cells. Infect Immun 36(2):782–794
Gonzalez-Bullon D, Uribe KB, Martin C, Ostolaza H (2017) Phospholipase A activity of adenylate cyclase toxin mediates translocation of its adenylate cyclase domain. Proc Natl Acad Sci U S A 114(33):E6784–E6793
Goodell EW (1985) Recycling of murein by Escherichia coli. J Bacteriol 163(1):305–310
Goodell EW, Fazio M, Tomasz A (1978) Effect of benzylpenicillin on the synthesis and structure of the cell envelope of Neisseria gonorrhoeae. Antimicrob Agents Chemother 13(3):514–526
Goodwin MS, Weiss AA (1990) Adenylate cyclase toxin is critical for colonization and pertussis toxin is critical for lethal infection by Bordetella pertussis in infant mice. Infect Immun 58(10):3445–3447
Gordon VM, Young WW Jr, Lechler SM, Gray MC, Leppla SH, Hewlett EL (1989) Adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis. Different processes for interaction with and entry into target cells. J Biol Chem 264(25):14792–14796
Gray M, Szabo G, Otero AS, Gray L, Hewlett E (1998) Distinct mechanisms for K+ efflux, intoxication, and hemolysis by Bordetella pertussis AC toxin. J Biol Chem 273(29):18260–18267
Gray MC, Ross W, Kim K, Hewlett EL (1999) Characterization of binding of adenylate cyclase toxin to target cells by flow cytometry. Infect Immun 67(9):4393–4399
Gray MC, Donato GM, Jones FR, Kim T, Hewlett EL (2004) Newly secreted adenylate cyclase toxin is responsible for intoxication of target cells by Bordetella pertussis. Mol Microbiol 53(6):1709–1719
Grimm M, Gsell S, Mittmann C, Nose M, Scholz H, Weil J, Eschenhagen T (1998) Inactivation of (Gialpha) proteins increases arrhythmogenic effects of beta-adrenergic stimulation in the heart. J Mol Cell Cardiol 30(10):1917–1928. https://doi.org/10.1006/jmcc.1998.0769
Gross MK, Au DC, Smith AL, Storm DR (1992) Targeted mutations that ablate either the adenylate cyclase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence. Proc Natl Acad Sci U S A 89(11):4898–4902
Gueirard P, Druilhe A, Pretolani M, Guiso N (1998) Role of adenylate cyclase-hemolysin in alveolar macrophage apoptosis during Bordetella pertussis infection in vivo. Infect Immun 66(4):1718–1725
Guermonprez P, Khelef N, Blouin E, Rieu P, Ricciardi-Castagnoli P, Guiso N, Ladant D, Leclerc C (2001) The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18). J Exp Med 193(9):1035–1044
Guo Q, Shen Y, Lee YS, Gibbs CS, Mrksich M, Tang WJ (2005) Structural basis for the interaction of Bordetella pertussis adenylyl cyclase toxin with calmodulin. EMBO J 24(18):3190–3201
Hackett M, Guo L, Shabanowitz J, Hunt DF, Hewlett EL (1994) Internal lysine palmitoylation in adenylate cyclase toxin from Bordetella pertussis. Science 266(5184):433–435
Hackett M, Walker CB, Guo L, Gray MC, Van Cuyk S, Ullmann A, Shabanowitz J, Hunt DF, Hewlett EL, Sebo P (1995) Hemolytic, but not cell-invasive activity, of adenylate cyclase toxin is selectively affected by differential fatty-acylation in Escherichia coli. J Biol Chem 270(35):20250–20253
Hanski E, Farfel Z (1985) Bordetella pertussis invasive adenylate cyclase. Partial resolution and properties of its cellular penetration. J Biol Chem 260(9):5526–5532
Harvill ET, Cotter PA, Yuk MH, Miller JF (1999) Probing the function of Bordetella bronchiseptica adenylate cyclase toxin by manipulating host immunity. Infect Immun 67(3):1493–1500
Hazes B, Boodhoo A, Cockle SA, Read RJ (1996) Crystal structure of the pertussis toxin-ATP complex: a molecular sensor. J Mol Biol 258(4):661–671
Hebeler BH, Young FE (1976) Chemical composition and turnover of peptidoglycan in Neisseria gonorrhoeae. J Bacteriol 126(3):1180–1185
Hewitt M, Canning BJ (2010) Coughing precipitated by Bordetella pertussis infection. Lung 188(Suppl 1):S73–S79
Hewlett EL, Urban MA, Manclark CR, Wolff J (1976) Extracytoplasmic adenylate cyclase of Bordetella pertussis. Proc Natl Acad Sci U S A 73(6):1926–1930
Hewlett EL, Manclark CR, Wolff J (1977) Adenyl cyclase in Bordetella pertussis vaccines. J Infect Dis 136(Suppl):S216–S219
Hewlett EL, Donato GM, Gray MC (2006) Macrophage cytotoxicity produced by adenylate cyclase toxin from Bordetella pertussis: more than just making cyclic AMP! Mol Microbiol 59(2):447–459
Hinds PW 2nd, Yin C, Salvato MS, Pauza CD (1996) Pertussis toxin induces lymphocytosis in rhesus macaques. J Med Primatol 25(6):375–381
Hodge G, Hodge S, Markus C, Lawrence A, Han P (2003) A marked decrease in L-selectin expression by leucocytes in infants with Bordetella pertussis infection: leucocytosis explained? Respirology 8(2):157–162
Hudnall SD, Molina CP (2000) Marked increase in L-selectin-negative T cells in neonatal pertussis. The lymphocytosis explained? Am J Clin Pathol 114(1):35–40
Jacobs C, Huang LJ, Bartowsky E, Normark S, Park JT (1994) Bacterial cell wall recycling provides cytosolic muropeptides as effectors for beta-lactamase induction. EMBO J 13(19):4684–4694
Jo YY, Lee JY, Park CK (2016) Resolvin E1 inhibits substance P-Induced potentiation of TRPV1 in primary sensory neurons. Mediat Inflamm 2016:5259321
Kamanova J, Kofronova O, Masin J, Genth H, Vojtova J, Linhartova I, Benada O, Just I, Sebo P (2008) Adenylate cyclase toxin subverts phagocyte function by RhoA inhibition and unproductive ruffling. J Immunol 181(8):5587–5597
Kapil P, Papin JF, Wolf RF, Zimmerman LI, Wagner LD, Merkel TJ (2018) Maternal vaccination with a monocomponent pertussis toxoid vaccine is sufficient to protect infants in a baboon model of whooping cough. J Infect Dis 217(8):1231–1236
Katada T (2012) The inhibitory G protein G(i) identified as pertussis toxin-catalyzed ADP-ribosylation. Biol Pharm Bull 35(12):2103–2111
Khelef N, Sakamoto H, Guiso N (1992) Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection. Microb Pathog 12(3):227–235
Khelef N, Zychlinsky A, Guiso N (1993) Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin. Infect Immun 61(10):4064–4071
Khelef N, Bachelet CM, Vargaftig BB, Guiso N (1994) Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins. Infect Immun 62(7):2893–2900
Kirimanjeswara GS, Agosto LM, Kennett MJ, Bjornstad ON, Harvill ET (2005) Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest 115(12):3594–3601
Kotani S, Tsujimoto M, Koga T, Nagao S, Tanaka A, Kawata S (1986) Chemical structure and biological activity relationship of bacterial cell walls and muramyl peptides. Fed Proc 45(11):2534–2540
Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, Petasis NA, Serhan CN (2010) Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci U S A 107(4):1660–1665
Krueger JM, Karnovsky ML (1987) Sleep and the immune response. Ann N Y Acad Sci 496:510–516
Krueger JM, Pappenheimer JR, Karnovsky ML (1982) Sleep-promoting effects of muramyl peptides. Proc Natl Acad Sci U S A 79(19):6102–6106
Levy BD, Serhan CN (2014) Resolution of acute inflammation in the lung. Annu Rev Physiol 76:467–492
Lim JH, Kim MS, Kim HE, Yano T, Oshima Y, Aggarwal K, Goldman WE, Silverman N, Kurata S, Oh BH (2006) Structural basis for preferential recognition of diaminopimelic acid-type peptidoglycan by a subset of peptidoglycan recognition proteins. J Biol Chem 281(12):8286–8295
Maddox JF, Hachicha M, Takano T, Petasis NA, Fokin VV, Serhan CN (1997) Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J Biol Chem 272(11):6972–6978
Magalhaes JG, Philpott DJ, Nahori MA, Jehanno M, Fritz J, Le Bourhis L, Viala J, Hugot JP, Giovannini M, Bertin J, Lepoivre M, Mengin-Lecreulx D, Sansonetti PJ, Girardin SE (2005) Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin. EMBO Rep 6(12):1201–1207
Maher SA, Dubuis ED, Belvisi MG (2011) G-protein coupled receptors regulating cough. Curr Opin Pharmacol 11(3):248–253
Mangmool S, Kurose H (2011) G(i/o) protein-dependent and -independent actions of pertussis toxin (PTX). Toxins 3(7):884–899
Martin SA, Karnovsky ML, Krueger JM, Pappenheimer JR, Biemann K (1984) Peptidoglycans as promoters of slow-wave sleep. I. Structure of the sleep-promoting factor isolated from human urine. J Biol Chem 259(20):12652–12658
Martin C, Requero MA, Masin J, Konopasek I, Goni FM, Sebo P, Ostolaza H (2004) Membrane restructuring by Bordetella pertussis adenylate cyclase toxin, a member of the RTX toxin family. J Bacteriol 186(12):3760–3765
Masin J, Osicka R, Bumba L, Sebo P (2015) Bordetella adenylate cyclase toxin: a unique combination of a pore-forming moiety with a cell-invading adenylate cyclase enzyme. Pathog Dis 73(8):ftv075
Masin J, Osicka R, Bumba L, Sebo P (2018) Phospholipase A activity of adenylate cyclase toxin? Proc Natl Acad Sci U S A 115(11):E2489–E2490
Mauck J, Chan L, Glaser L (1971) Turnover of the cell wall of Gram-positive bacteria. J Biol Chem 246(6):1820–1827
Melly MA, McGee ZA, Rosenthal RS (1984) Ability of monomeric peptidoglycan fragments from Neisseria gonorrhoeae to damage human fallopian-tube mucosa. J Infect Dis 149(3):378–386
Mielcarek N, Riveau G, Remoue F, Antoine R, Capron A, Locht C (1998) Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis. Nat Biotechnol 16(5):454–457
Mielcarek N, Debrie AS, Raze D, Bertout J, Rouanet C, Younes AB, Creusy C, Engle J, Goldman WE, Locht C (2006) Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog 2(7):e65
Mobberley-Schuman PS, Connelly B, Weiss AA (2003) Phagocytosis of Bordetella pertussis incubated with convalescent serum. J Infect Dis 187(10):1646–1653
Montgomery MK, McFall-Ngai M (1994) Bacterial symbionts induce host organ morphogenesis during early postembryonic development of the squid Euprymna scolopes. Development 120(7):1719–1729
Morse SI, Morse JH (1976) Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis. J Exp Med 143(6):1483–1502
Munoz JJ, Arai H, Bergman RK, Sadowski PL (1981) Biological activities of crystalline pertussigen from Bordetella pertussis. Infect Immun 33(3):820–826
Munoz JJ, Bernard CC, Mackay IR (1984) Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen. Cell Immunol 83(1):92–100
Nguyen AW, Wagner EK, Laber JR, Goodfield LL, Smallridge WE, Harvill ET, Papin JF, Wolf RF, Padlan EA, Bristol A, Kaleko M, Maynard JA (2015) A cocktail of humanized anti-pertussis toxin antibodies limits disease in murine and baboon models of whooping cough. Sci Transl Med 7(316):316ra195
Njamkepo E, Pinot F, Francois D, Guiso N, Polla BS, Bachelet M (2000) Adaptive responses of human monocytes infected by Bordetella pertussis: the role of adenylate cyclase hemolysin. J Cell Physiol 183(1):91–99
Nogimori K, Ito K, Tamura M, Satoh S, Ishii S, Ui M (1984) Chemical modification of islet-activating protein, pertussis toxin. Essential role of free amino groups in its lymphocytosis-promoting activity. Biochim Biophys Acta 801(2):220–231
Orr B, Douce G, Baillie S, Parton R, Coote J (2007) Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of mice. Vaccine 25(1):64–71
Osickova A, Osicka R, Maier E, Benz R, Sebo P (1999) An amphipathic alpha-helix including glutamates 509 and 516 is crucial for membrane translocation of adenylate cyclase toxin and modulates formation and cation selectivity of its membrane channels. J Biol Chem 274(53):37644–37650
Osickova A, Masin J, Fayolle C, Krusek J, Basler M, Pospisilova E, Leclerc C, Osicka R, Sebo P (2010) Adenylate cyclase toxin translocates across target cell membrane without forming a pore. Mol Microbiol 75(6):1550–1562
Oskouizadeh K, Selk-Ghafari M, Zahraei-Salehi T, Dezfolian O (2011) Isolation of Bordetella bronchiseptica in a dog with tracheal collapse. Comp Clin Pathol 20(5):153–158
Ostolaza H (2018) Reply to Masin et al: to be or not to be a phospholipase A. Proc Natl Acad Sci U S A 115(11):E2491
Ostolaza H, Martin C, Gonzalez-Bullon D, Uribe KB, Etxaniz A (2017) Understanding the mechanism of translocation of adenylate cyclase toxin across biological membranes. Toxins (Basel) 9(10)
Paddock CD, Sanden GN, Cherry JD, Gal AA, Langston C, Tatti KM, Wu KH, Goldsmith CS, Greer PW, Montague JL, Eliason MT, Holman RC, Guarner J, Shieh WJ, Zaki SR (2008) Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis 47(3):328–338
Paik D, Monahan A, Caffrey DR, Elling R, Goldman WE, Silverman N (2017) SLC46 family transporters facilitate cytosolic innate immune recognition of monomeric peptidoglycans. J Immunol 199(1):263–270
Pande AH, Moe D, Jamnadas M, Tatulian SA, Teter K (2006) The pertussis toxin S1 subunit is a thermally unstable protein susceptible to degradation by the 20S proteasome. Biochemistry 45(46):13734–13740
Parton R, Hall E, Wardlaw AC (1994) Responses to Bordetella pertussis mutant strains and to vaccination in the coughing rat model of pertussis. J Med Microbiol 40(5):307–312
Pearson RD, Symes P, Conboy M, Weiss AA, Hewlett EL (1987) Inhibition of monocyte oxidative responses by Bordetella pertussis adenylate cyclase toxin. J Immunol 139(8):2749–2754
Pham TH, Okada T, Matloubian M, Lo CG, Cyster JG (2008) S1P1 receptor signaling overrides retention mediated by G alpha i-coupled receptors to promote T cell egress. Immunity 28(1):122–133
Pierce C, Klein N, Peters M (2000) Is leukocytosis a predictor of mortality in severe pertussis infection? Intensive Care Med 26(10):1512–1514
Plaut RD, Carbonetti NH (2008) Retrograde transport of pertussis toxin in the mammalian cell. Cell Microbiol 10(5):1130–1139
Plaut RD, Scanlon KM, Taylor M, Teter K, Carbonetti NH (2016) Intracellular disassembly and activity of pertussis toxin require interaction with ATP. Pathog Dis 74(6):ftw065
Rogel A, Meller R, Hanski E (1991) Adenylate cyclase toxin from Bordetella pertussis. The relationship between induction of cAMP and hemolysis. J Biol Chem 266(5):3154–3161
Rose T, Sebo P, Bellalou J, Ladant D (1995) Interaction of calcium with Bordetella pertussis adenylate cyclase toxin. Characterization of multiple calcium-binding sites and calcium-induced conformational changes. J Biol Chem 270(44):26370–26376
Rosenthal RS, Nogami W, Cookson BT, Goldman WE, Folkening WJ (1987) Major fragment of soluble peptidoglycan released from growing Bordetella pertussis is tracheal cytotoxin. Infect Immun 55(9):2117–2120
Ross PJ, Lavelle EC, Mills KH, Boyd AP (2004) Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells. Infect Immun 72(3):1568–1579
Ross PJ, Sutton CE, Higgins S, Allen AC, Walsh K, Misiak A, Lavelle EC, McLoughlin RM, Mills KH (2013) Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog 9(4):e1003264
Rowlands HE, Goldman AP, Harrington K, Karimova A, Brierley J, Cross N, Skellett S, Peters MJ (2010) Impact of rapid leukodepletion on the outcome of severe clinical pertussis in young infants. Pediatrics 126(4):e816–e827
Rubin K, Glazer S (2016) The potential role of subclinical Bordetella Pertussis colonization in the etiology of multiple sclerosis. Immunobiology 221(4):512–515
Scanlon KM, Gau Y, Zhu J, Skerry C, Wall SM, Soleimani M, Carbonetti NH (2014) Epithelial anion transporter pendrin contributes to inflammatory lung pathology in mouse models of Bordetella pertussis infection. Infect Immun 82(10):4212–4221
Scanlon KM, Snyder YG, Skerry C, Carbonetti NH (2017) Fatal pertussis in the neonatal mouse model is associated with pertussis toxin-mediated pathology beyond the airways. Infect Immun 85(11)
Schenkel AR, Pauza CD (1999) Pertussis toxin treatment in vivo reduces surface expression of the adhesion integrin leukocyte function antigen-1 (LFA-1). Cell Adhes Commun 7(3):183–193
Schneider OD, Weiss AA, Miller WE (2009) Pertussis toxin signals through the TCR to initiate cross-desensitization of the chemokine receptor CXCR4. J Immunol 182(9):5730–5739
Sebo P, Ladant D (1993) Repeat sequences in the Bordetella pertussis adenylate cyclase toxin can be recognized as alternative carboxy-proximal secretion signals by the Escherichia coli alpha-haemolysin translocator. Mol Microbiol 9(5):999–1009
Skerry CM, Mahon BP (2011) A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model. Clin Vaccine Immunol 18(2):187–193
Skerry CM, Cassidy JP, English K, Feunou-Feunou P, Locht C, Mahon BP (2009) A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice. Clin Vaccine Immunol 16(9):1344–1351
Skerry C, Goldman WE, Carbonetti NH (2019) Peptidoglycan recognition protein 4 suppresses early inflammatory responses to Bordetella pertussis and contributes to Sphingosine-1-Phosphate receptor agonist-mediated disease attenuation. Infect Immun 87(2)
Skopova K, Tomalova B, Kanchev I, Rossmann P, Svedova M, Adkins I, Bibova I, Tomala J, Masin J, Guiso N, Osicka R, Sedlacek R, Kovar M, Sebo P (2017) Cyclic AMP-elevating capacity of adenylate cyclase toxin-hemolysin is sufficient for lung infection but not for full virulence of Bordetella pertussis. Infect Immun 85(6):pii: e00937-16
Spensieri F, Fedele G, Fazio C, Nasso M, Stefanelli P, Mastrantonio P, Ausiello CM (2006) Bordetella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction. Infect Immun 74(5):2831–2838
Surridge J, Segedin ER, Grant CC (2007) Pertussis requiring intensive care. Arch Dis Child 92(11):970–975
Svedova M, Masin J, Fiser R, Cerny O, Tomala J, Freudenberg M, Tuckova L, Kovar M, Dadaglio G, Adkins I, Sebo P (2016) Pore-formation by adenylate cyclase toxoid activates dendritic cells to prime CD8+ and CD4+ T cells. Immunol Cell Biol 94(4):322–333
Szabo G, Gray MC, Hewlett EL (1994) Adenylate cyclase toxin from Bordetella pertussis produces ion conductance across artificial lipid bilayers in a calcium- and polarity-dependent manner. J Biol Chem 269(36):22496–22499
Thierry-Carstensen B, Dalby T, Stevner MA, Robbins JB, Schneerson R, Trollfors B (2013) Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience. Vaccine 31(45):5178–5191
Thorstensson R, Trollfors B, Al-Tawil N, Jahnmatz M, Bergstrom J, Ljungman M, Torner A, Wehlin L, Van Broekhoven A, Bosman F, Debrie AS, Mielcarek N, Locht C (2014) A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. PLoS One 9(1):e83449
Uehara T, Park JT (2008) Peptidoglycan recycling. EcoSal Plus 3(1)
Uribe KB, Etxebarria A, Martin C, Ostolaza H (2013) Calpain-mediated processing of adenylate cyclase toxin generates a cytosolic soluble catalytically active n-terminal domain. PLoS One 8(6):e67648
Valdez HA, Oviedo JM, Gorgojo JP, Lamberti Y, Rodriguez ME (2016) Bordetella pertussis modulates human macrophage defense gene expression. Pathog Dis 74(6):ftw073
Vojtova J, Kamanova J, Sebo P (2006) Bordetella adenylate cyclase toxin: a swift saboteur of host defense. Curr Opin Microbiol 9(1):69–75
Wainford RD, Kurtz K, Kapusta DR (2008) Central G-alpha subunit protein-mediated control of cardiovascular function, urine output, and vasopressin secretion in conscious Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 295(2):R535–R542
Wang X, Gray MC, Hewlett EL, Maynard JA (2015) The Bordetella adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies. J Biol Chem 290(6):3576–3591
Warfel JM, Merkel TJ (2014) The baboon model of pertussis: effective use and lessons for pertussis vaccines. Expert Rev Vaccines 13(10):1241–1252
Warfel JM, Beren J, Kelly VK, Lee G, Merkel TJ (2012) Nonhuman primate model of pertussis. Infect Immun 80(4):1530–1536
Warnock RA, Askari S, Butcher EC, von Andrian UH (1998) Molecular mechanisms of lymphocyte homing to peripheral lymph nodes. J Exp Med 187(2):205–216
Weingart CL, Weiss AA (2000) Bordetella pertussis virulence factors affect phagocytosis by human neutrophils. Infect Immun 68(3):1735–1739
Weingart CL, Mobberley-Schuman PS, Hewlett EL, Gray MC, Weiss AA (2000) Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils. Infect Immun 68(12):7152–7155
Weiss AA, Goodwin MS (1989) Lethal infection by Bordetella pertussis mutants in the infant mouse model. Infect Immun 57(12):3757–3764
Weiss AA, Hewlett EL, Myers GA, Falkow S (1983) Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect Immun 42(1):33–41
Winter K, Zipprich J, Harriman K, Murray EL, Gornbein J, Hammer SJ, Yeganeh N, Adachi K, Cherry JD (2015) Risk factors associated with infant deaths from pertussis: a case-control study. Clin Infect Dis 61(7):1099–1106
Witvliet MH, Burns DL, Brennan MJ, Poolman JT, Manclark CR (1989) Binding of pertussis toxin to eucaryotic cells and glycoproteins. Infect Immun 57(11):3324–3330
Wolff J, Cook GH, Goldhammer AR, Berkowitz SA (1980) Calmodulin activates prokaryotic adenylate cyclase. Proc Natl Acad Sci U S A 77(7):3841–3844
Wong WS, Rosoff PM (1996) Pharmacology of pertussis toxin B-oligomer. Can J Physiol Pharmacol 74(5):559–564
Worthington ZE, Carbonetti NH (2007) Evading the proteasome: absence of lysine residues contributes to pertussis toxin activity by evasion of proteasome degradation. Infect Immun 75(6):2946–2953
Yajima M, Hosoda K, Kanbayashi Y, Nakamura T, Nogimori K, Mizushima Y, Nakase Y, Ui M (1978) Islets-activating protein (IAP) in Bordetella pertussis that potentiates insulin secretory responses of rats. Purification and characterization. J Biochem 83(1):295–303
Zaretzky FR, Gray MC, Hewlett EL (2002) Mechanism of association of adenylate cyclase toxin with the surface of Bordetella pertussis: a role for toxin-filamentous haemagglutinin interaction. Mol Microbiol 45(6):1589–1598
Zhao CB, Coons SW, Cui M, Shi FD, Vollmer TL, Ma CY, Kuniyoshi SM, Shi J (2008) A new EAE model of brain demyelination induced by intracerebroventricular pertussis toxin. Biochem Biophys Res Commun 370(1):16–21
Zheng M, Zhu W, Han Q, Xiao RP (2005) Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling. Pharmacol Ther 108(3):257–268
Zocchi MR, Contini P, Alfano M, Poggi A (2005) Pertussis toxin (PTX) B subunit and the nontoxic PTX mutant PT9K/129G inhibit Tat-induced TGF-beta production by NK cells and TGF-beta-mediated NK cell apoptosis. J Immunol 174(10):6054–6061
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Scanlon, K., Skerry, C., Carbonetti, N. (2019). Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis. In: Fedele, G., Ausiello, C. (eds) Pertussis Infection and Vaccines. Advances in Experimental Medicine and Biology(), vol 1183. Springer, Cham. https://doi.org/10.1007/5584_2019_403
Download citation
DOI: https://doi.org/10.1007/5584_2019_403
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-33248-8
Online ISBN: 978-3-030-33249-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)